Experimental Data Snapshot
Starting Model:experimental
View more details
(2015) Structure 23: 2246
The destabilizing p53 cancer mutation Y220C creates an extended crevice on the surface of the protein that can be targeted by small-molecule stabilizers. Here, we identify different classes of small molecules that bind to this crevice and determine their binding modes by X-ray crystallography. These structures reveal two major conformational states of the pocket and a cryptic, transiently open hydrophobic subpocket that is modulated by Cys220. In one instance, specifically targeting this transient protein state by a pyrrole moiety resulted in a 40-fold increase in binding affinity. Molecular dynamics simulations showed that both open and closed states of this subsite were populated at comparable frequencies along the trajectories. Our data extend the framework for the design of high-affinity Y220C mutant binders for use in personalized anticancer therapy and, more generally, highlight the importance of implementing protein dynamics and hydration patterns in the drug-discovery process.
 Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (Y0V)
Biological assembly 1 assigned by authors and generated by PISA (software)
 Explore in 3D: Structure |Sequence Annotations |Electron Density |Validation Report |Ligand Interaction (Y0V)
Biological assembly 2 assigned by authors and generated by PISA (software)
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| CELLULAR TUMOR ANTIGEN P53 | 219 | Homo sapiens | Mutation(s): 5  | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P04637 (Homo sapiens) Explore P04637  Go to UniProtKB:  P04637 | |||||
PHAROS:  P04637 GTEx:  ENSG00000141510  | |||||
Entity Groups  | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P04637 | ||||
Sequence AnnotationsExpand | |||||
| |||||
| Ligands 3 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| Y0V Query on Y0V Download Ideal Coordinates CCD File  | C [auth A], F [auth B] | 2-hydroxy-3,5-diiodo-4-(1H-pyrrol-1-yl)benzoic acid C11 H7 I2 N O3 YWYHXCFRZDCHOC-UHFFFAOYSA-N | |||
| PEG Query on PEG Download Ideal Coordinates CCD File  | E [auth B] | DI(HYDROXYETHYL)ETHER C4 H10 O3 MTHSVFCYNBDYFN-UHFFFAOYSA-N | |||
| ZN Query on ZN Download Ideal Coordinates CCD File  | D [auth A], G [auth B] | ZINC ION Zn PTFCDOFLOPIGGS-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 65.216 | α = 90 |
| b = 71.108 | β = 90 |
| c = 105.353 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.